Outcomes for matched patients with metastatic colitis-associated cancers versus sporadic colorectal cancer receiving chemotherapy.

被引：0
|
作者：
Yaeger, Rona
Hersch, Jonathan
Bates, David
Paroder, Viktoriya
Chou, Joanne F.
Tang, Laura H.
Gollub, Marc Jeffrey
Capanu, Marinela
Kelsen, David Paul
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] NRG Oncol, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Weill Cornell Med Coll, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e15534
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15534
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Systemic Chemotherapy for Metastatic Colitis-Associated Cancer Has a Worse Outcome Than Sporadic Colorectal Cancer: Matched Case Cohort Analysis
    Yaeger, Rona
    Paroder, Viktoriya
    Bates, David D. B.
    Capanu, Marinela
    Chou, Joanne
    Tang, Laura
    Chatila, Walid
    Schultz, Nikolaus
    Hersch, Jonathan
    Kelsen, David
    CLINICAL COLORECTAL CANCER, 2020, 19 (04) : E151 - E156
  • [2] Long-Term Outcomes After Colorectal Surgery in Patients with Ulcerative Colitis-Associated Colorectal Cancer Versus Sporadic Colorectal Cancer
    Lin, Viviane A.
    Lohse, Robin
    Madsen, Michael T.
    Fransgaard, Tina
    Remzi, Feza H.
    Goegenur, Ismail
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (04) : 2505 - 2512
  • [3] Long-Term Outcomes After Colorectal Surgery in Patients with Ulcerative Colitis-Associated Colorectal Cancer Versus Sporadic Colorectal Cancer
    Viviane A. Lin
    Robin Lohse
    Michael T. Madsen
    Tina Fransgaard
    Feza H. Remzi
    Ismail Gögenur
    Annals of Surgical Oncology, 2022, 29 : 2505 - 2512
  • [4] Tumor immune environment in colitis-associated colorectal cancers: Comparison with sporadic colorectal cancers
    Li, Wenliang
    Xu, Ning
    Huang, Fengchang
    Yu, Kun
    Yang, Quan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal Cancer
    Schardey, Josefine
    Lu, Can
    Neumann, Jens
    Wirth, Ulrich
    Li, Qiang
    Jiang, Tianxiao
    Zimmermann, Petra
    Andrassy, Joachim
    Bazhin, Alexandr V.
    Werner, Jens
    Kuehn, Florian
    CANCERS, 2023, 15 (19)
  • [6] Differences between sporadic and colitis-associated colorectal cancer
    Itzkowitz, S. H.
    INTESTINAL INFLAMMATION AND COLORECTAL CANCER, 2007, 158 : 92 - 104
  • [7] Clinical Characteristics, Management, and Outcomes of Colitis-Associated Colorectal Cancer and the Comparison With Sporadic Colorectal Cancer in Taiwan
    Wu, Hsin-Yun
    Weng, Meng-Tzu
    Chou, Jen-Wei
    Yen, Hsu-Heng
    Lin, Chun-Chi
    Chiang, Feng-Fan
    Chung, Chen-Shuan
    Lin, Wei-Chen
    Chang, Chen-Wang
    Le, Puo-Hsien
    Kuo, Chia-Jung
    Lin, Ching-Pin
    Hsu, Wen-Hung
    Chuang, Chiao-Hsiung
    Tsai, Tzung-Jiun
    Feng, I-Che
    Wei, Shu-Chen
    Huang, Tien-Yu
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2025, 16 (02)
  • [8] LONG-TERM OUTCOMES OF SPORADIC COLON CANCER VERSUS ULCERATIVE COLITIS-ASSOCIATED COLON CANCER: A CASE MATCHED STUDY.
    Tatar, C.
    Lightner, A.
    Liska, D.
    Kalady, M.
    Steele, S.
    Gorgun, E.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E301 - E301
  • [9] Therapy monitoring with FDG PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss, A
    Strauss, L
    Rudi, J
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 22P - 23P
  • [10] Carcinoembryonic antigen (CEA) surge in patients with metastatic colorectal cancer receiving systemic chemotherapy.
    Sunga, AY
    Ailawadhi, S
    Yang, GY
    Rajput, A
    Smith, JL
    Fakih, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 274S - 274S
12345